Research Report for: bluebird bio, Inc. (NASDAQ:BLUE)


bluebird bio, Inc. (NASDAQ:BLUE) will report its next earnings on Nov 2 – Nov 7 (Est.). The company reported the earnings of $-1.59/Share in the last quarter where the estimated EPS by analysts was $-1.44/share. The difference between the expected and actual EPS was $-0.15/share, which represents an Earnings surprise of -10.4%.

Many analysts are providing their Estimated Earnings analysis for bluebird bio, Inc. and for the current quarter 14 analysts have projected that the stock could give an Average Earnings estimate of $-1.51/share. These analysts have also projected a Low Estimate of $-1.77/share and a High Estimate of $-0.55/share.

In case of Revenue Estimates, 15 analysts have provided their consensus Average Revenue Estimates for bluebird bio, Inc. as 1.78 Million. According to these analysts, the Low Revenue Estimate for bluebird bio, Inc. is 1 Billion and the High Revenue Estimate is 3 Million. The company had Year Ago Sales of 1.32 Million.

Some buy side analysts are also providing their Analysis on bluebird bio, Inc., where 6 analysts have rated the stock as Strong buy, 7 analysts have given a Buy signal, 3 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. 13 Analysts reported that the Price Target for bluebird bio, Inc. might touch $135 high while the Average Price Target and Low price Target is $86.31 and $37 respectively.

To analyze a stock, one should look for Upgrades and Downgrades of a stock. bluebird bio, Inc. got Downgrade on 14-Oct-16 where investment firm Cantor Fitzgerald Downgrade the stock from Hold to Sell.

bluebird bio, Inc. closed its last trading session at $55.5 with the loss of -1.08%. The Market Capitalization of the company stands at 2.35 Billion. The Company has 52-week high of $99.7 and 52-week low of $35.37. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -20.25% where SMA50 and SMA200 are -10.11% and 9.73% respectively. The Company Touched its 52-Week High on Nov 4, 2015 and 52-Week Low on May 12, 2016.

The Relative Volume of the company is 0.99 and Average Volume (3 months) is 1.21 million. bluebird bio, Inc. P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -20.8%. The Return on Equity (ROE) value stands at -24.8%. While it’s Return on Investment (ROI) value is -18.5%.

While looking at the Stock’s Performance, bluebird bio, Inc. currently shows a Weekly Performance of -21.61%, where Monthly Performance is -22.62%, Quarterly performance is 14.16%, 6 Months performance is 23.9% and yearly performance percentage is -32.91%. Year to Date performance value (YTD perf) value is -14.51%. The Stock currently has a Weekly Volatility of 7.89% and Monthly Volatility of 5.97%.